Larvol Delta - Intravenous-Iloprost-in-Subjects-With-Symptomatic-Raynaud39s-Phenomenon-Secondary-to-Systemic-Sclerosis-Phase-3

iloprost intravenous (CIVI030) - CiVi Biopharma

Ventavis (iloprost ) - Bayer, J&J, University of Copenhagen

http://clinicaltrials.gov/ct2/show/NCT04040322

Oct 5, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next